Skip to main content
OpenTrials
Completed

NCT Number: NCT04337489

Remote Monitoring Use In Cases Of Suspected COVID-19 (Coronavirus)

The study aims to see if participant deterioration due to suspected coronavirus in a designated location (e.g. hotel) can be identified sooner by wearing the sensor. If sick patients can be identified early, participants are more likely to have better outcomes; the study believes that the sensor can help us do this. The sensor measures heart rate, respiratory rate and temperature every 2 minutes and this can be reviewed by the clinical team looking after the participants.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Coronavirus Coronaviridae Infections Coronavirus Infections Infections Nidovirales Infections RNA Virus Infections Virus Diseases

Age range

18 year–95 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Imperial College London

London, United Kingdom

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Aged 18 years or over.
  • Able to provide written consent.

Exclusion criteria

  • Any participants that withdraw their consent.
  • A skin condition/reaction preventing wearing the wearable sensor.
  • The presence of a permanent pacemaker or cardiac defibrillator.
  • Any form of psychiatric disorder or a condition that, in the opinion of the investigator, may hinder communication with the research team.
  • Inability to cooperate or communicate with the research team.

Treatment and study plan

SensiumVitals wearable sensor

Device

A waterproof, light, wearable sensor measuring vital signs (heart rate, respiratory rate, temperature) continuously.

Primary outcomes

  1. Deterioration Resulting in Healthcare Review

    Time frame: 1 year

    Detection of clinical deterioration using wearable sensors resulting in healthcare review (e.g. GP telephone consultation)

Secondary outcomes

  1. Hospitalisation

    Time frame: 1 year

    Deterioration resulting in hospitalisation

Sponsors and collaborators

Lead sponsor

Imperial College London

Other

Collaborators

  • CW+ Charity

Registry information

Official study title

REmote MOniToring usE in Suspected Cases of COVID-19 (Coronavirus): REMOTE-COVID Trial

Acronym: REMOTE-COVID

Important dates

Study start
2020
Primary completion
2021
Study completion
2021
First posted
Apr 7, 2020
Registry last updated
Oct 8, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.